Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Intec Pharma Ltd. (NTEC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K20-F20-F20-F20-F
Revenues  0.01.50.90.315.47.65.25.2
            Revenue growth  -100.0%76.1%197.9%-98.1%103.7%45.4%-0.1% 
Cost of goods sold  0.00.00.90.30.00.00.00.0
Gross profit  0.01.50.00.015.47.65.25.2
            Gross margin   100.0%0.0%0.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]7.18.37.95.13.12.82.62.4
Research and development  6.726.735.424.326.112.38.47.8
EBITDA   [+]-12.6-32.6-42.5-28.6    
            EBITDA margin   -2172.8%-4984.6%-10003.5%-89.8%-100.4%-111.4%-96.9%
Depreciation and amortization  1.20.90.90.8    
EBIT   [+]-13.8-33.4-43.3-29.4-13.8-7.6-5.8-5.0
            EBIT margin   -2229.7%-5085.4%-10293.4%-89.8%-100.4%-111.4%-96.9%
Non-recurring items   [+] 13.7      
Other income (expense), net  -0.20.1-0.10.60.40.40.1-0.1
Pre-tax income  -14.0-47.0-43.4-28.9-13.4-7.2-5.7-5.1
Income taxes  0.10.60.10.00.00.00.00.0
            Tax rate      0.0%0.0%0.0%0.0%
Net income  -14.1-47.6-43.5-28.9-13.4-7.2-5.7-5.1
            Net margin   -3173.3%-5110.7%-10108.0%-86.9%-95.1%-109.6%-98.1%
   
Basic EPS   [+]($4.08)($28.18)($1.40)($1.64)    
Diluted EPS   [+]($4.08)($28.18)($1.40)($1.64)    
   
Shares outstanding (basic)   [+]3.51.731.217.7    
Shares outstanding (diluted)   [+]3.51.731.217.7    
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy